Cargando…
Facing Real-World Challenges of Immunogenicity in Pediatric Inflammatory Bowel Disease
Autores principales: | Gress, Kyle, Bass, Julie A., Funk, Ryan S., Morrow, Ryan P., Hasenkamp, Rachel, Shakhnovich, Valentina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295975/ https://www.ncbi.nlm.nih.gov/pubmed/32582213 http://dx.doi.org/10.3389/fimmu.2020.01148 |
Ejemplares similares
-
Potential Role of Methotrexate Polyglutamates in Therapeutic Drug Monitoring for Pediatric Inflammatory Bowel Disease
por: Morrow, Ryan, et al.
Publicado: (2021) -
Immunogenicity in Clinical Practice and Drug Development: When is it Significant?
por: Shakhnovich, Valentina, et al.
Publicado: (2019) -
Factors associated with reduced infliximab exposure in the treatment of pediatric autoimmune disorders: a cross-sectional prospective convenience sampling study
por: Funk, Ryan S., et al.
Publicado: (2021) -
Investigation of potential early Histologic markers of pediatric inflammatory bowel disease
por: Bass, Julie A., et al.
Publicado: (2015) -
fMRI in Translation: The Challenges Facing Real-World Applications
por: Schleim, Stephan, et al.
Publicado: (2009)